Veracyte Balance Sheet
NASDAQ: VCYTHealth CareMedical SpecialitiesUSD
At close: Oct 9, 4:00 PM ET · Delayed 15 min
Veracyte financial position
At the end of fiscal 2025, Veracyte reported total assets of $1.41 billion, up 8.2% from a year earlier against total liabilities of $96.4 million. Shareholders' equity stood at $1.31 billion, or 93.1% of assets. The company held $362.6 million in cash and equivalents.
The current ratio (current assets divided by current liabilities) was 8.15, meaning short-term assets cover obligations due within a year.
Summary generated from market data by MetaCap's automated system. Methodology
Veracyte balance sheet (annual)
| Fiscal year (USD) | FY 20252025-12-31 | FY 20242024-12-31 | FY 20232023-12-31 | FY 20222022-12-31 | FY 20212021-12-31 | FY 20202020-12-31 | FY 20192019-12-31 | FY 20182018-12-31 | FY 20172017-12-31 | FY 20162016-12-31 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash & Equivalents | 362.58M | 239.09M | 216.45M | 154.25M | 173.20M | 349.36M | 159.32M | 78.00M | 33.89M | 59.22M |
| Short-Term Investments | 50.31M | — | — | — | — | — | — | — | — | — |
| Receivables | 44.66M | 46.52M | 40.38M | 44.02M | 41.46M | 18.46M | 19.33M | 13.17M | 12.72M | 8.76M |
| Inventory | 20.55M | 21.75M | 16.13M | 14.29M | 11.22M | 4.66M | 6.81M | 3.40M | 5.32M | 3.48M |
| Total Current Assets | 488.38M | 372.27M | 285.62M | 248.64M | 243.10M | 375.68M | 187.69M | 96.95M | 53.93M | 73.63M |
| Property, Plant & Equipment | 22.19M | 22.95M | 20.58M | 17.70M | 15.10M | 8.99M | 8.93M | 8.94M | 9.69M | 11.48M |
| Goodwill | 767.15M | 745.80M | 702.98M | 695.89M | 707.90M | 2.73M | 2.73M | 1.06M | 1.06M | 1.06M |
| Intangible Assets | 89.15M | 102.30M | 88.59M | 174.87M | 202.73M | 59.92M | 65.02M | 12.00M | 13.07M | 14.13M |
| Total Assets | 1.41B | 1.30B | 1.11B | 1.16B | 1.19B | 457.16M | 275.21M | 120.64M | 78.67M | 101.03M |
| Accounts Payable | 4.59M | 8.63M | 12.94M | 11.91M | 12.36M | 3.12M | 2.33M | 2.52M | 3.85M | 2.42M |
| Short-Term Debt | — | — | — | 0 | 1.13M | 0 | 0 | 1.36M | 0 | — |
| Total Current Liabilities | 59.94M | 78.63M | 61.24M | 62.61M | 64.15M | 16.78M | 17.47M | 13.06M | 12.03M | 11.53M |
| Long-Term Debt | — | — | — | — | 0 | 810.00K | 694.00K | 23.93M | 24.94M | 24.92M |
| Total Liabilities | 96.44M | 124.07M | 70.80M | 81.22M | 91.31M | 35.93M | 35.76M | 40.88M | 41.44M | 41.45M |
| Shareholders' Equity | 1.31B | 1.18B | 1.04B | 1.08B | 1.10B | 421.23M | 239.46M | 79.75M | 37.23M | 59.58M |
| Retained Earnings | -377.63M | -443.98M | -468.12M | -393.72M | -357.16M | -281.59M | -246.69M | -234.09M | -211.09M | -180.08M |
| Total Debt | — | — | — | 0 | 1.13M | 810.00K | 694.00K | 25.28M | 24.94M | 24.92M |
| Net Cash (Debt) | 412.89M | 239.09M | 216.45M | 154.25M | 172.07M | 348.55M | 158.62M | 52.71M | 8.95M | 34.30M |
| Shares Outstanding | 79.36M | 77.77M | 73.26M | 71.96M | 71.12M | 58.20M | 49.63M | 40.86M | 33.76M | 33.76M |
This table shows 10 annual periods of Veracyte's balance sheet, from FY 2025 back to FY 2016, across 19 line items including cash & equivalents, short-term investments, receivables. Values in USD; B = billions, M = millions. Fiscal periods follow VCYT's reporting calendar. What is a balance sheet?